Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753203
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-31
First Post:
2021-02-04
Brief Title:
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
Sponsor:
Korean Cancer Study Group
Organization:
Korean Cancer Study Group
Organization Data
Organization:
Korean Cancer Study Group
Class:
OTHER
Study ID:
K2020-2011-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Korean Cancer Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
SoohyeonLee
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Korean Cancer Study Group
Old Name:
None
Old Organization:
None